

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | creatine metabolic process (GO:0006600) | 5.68507823 |
| 2 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 5.54447178 |
| 3 | amyloid precursor protein catabolic process (GO:0042987) | 5.36416874 |
| 4 | muscle cell fate commitment (GO:0042693) | 5.23807046 |
| 5 | actin-myosin filament sliding (GO:0033275) | 5.14101529 |
| 6 | muscle filament sliding (GO:0030049) | 5.14101529 |
| 7 | regulation of skeletal muscle contraction (GO:0014819) | 5.00822105 |
| 8 | skeletal muscle contraction (GO:0003009) | 4.87428070 |
| 9 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.86170810 |
| 10 | tooth mineralization (GO:0034505) | 4.82240973 |
| 11 | muscle organ morphogenesis (GO:0048644) | 4.73525424 |
| 12 | apoptotic process involved in morphogenesis (GO:0060561) | 4.51432545 |
| 13 | negative regulation of erythrocyte differentiation (GO:0045647) | 4.39293079 |
| 14 | skeletal muscle fiber development (GO:0048741) | 4.29300470 |
| 15 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.24503605 |
| 16 | viral transcription (GO:0019083) | 4.09088910 |
| 17 | amyloid precursor protein metabolic process (GO:0042982) | 3.97753697 |
| 18 | positive regulation of myotube differentiation (GO:0010831) | 3.92535161 |
| 19 | mannose metabolic process (GO:0006013) | 3.90347699 |
| 20 | actin-mediated cell contraction (GO:0070252) | 3.82437858 |
| 21 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 3.67064782 |
| 22 | ribosomal small subunit biogenesis (GO:0042274) | 3.61024454 |
| 23 | translational termination (GO:0006415) | 3.60325184 |
| 24 | myotube cell development (GO:0014904) | 3.37067357 |
| 25 | myofibril assembly (GO:0030239) | 3.33670548 |
| 26 | sulfur amino acid catabolic process (GO:0000098) | 3.30757306 |
| 27 | response to peptidoglycan (GO:0032494) | 3.29057346 |
| 28 | sarcomere organization (GO:0045214) | 3.26526131 |
| 29 | apoptotic process involved in development (GO:1902742) | 3.25257522 |
| 30 | striated muscle contraction (GO:0006941) | 3.24912164 |
| 31 | pentose metabolic process (GO:0019321) | 3.19227618 |
| 32 | activation of MAPKKK activity (GO:0000185) | 3.08903281 |
| 33 | adenosine receptor signaling pathway (GO:0001973) | 3.07333604 |
| 34 | proline biosynthetic process (GO:0006561) | 3.07105707 |
| 35 | response to muscle activity (GO:0014850) | 3.06371728 |
| 36 | translational elongation (GO:0006414) | 3.03999031 |
| 37 | embryonic viscerocranium morphogenesis (GO:0048703) | 3.03215970 |
| 38 | regulation of chromatin binding (GO:0035561) | 3.02314323 |
| 39 | actin filament-based movement (GO:0030048) | 2.99340450 |
| 40 | respiratory tube development (GO:0030323) | 2.97209932 |
| 41 | viral life cycle (GO:0019058) | 2.96638784 |
| 42 | positive regulation of triglyceride biosynthetic process (GO:0010867) | 2.94991740 |
| 43 | oxidative phosphorylation (GO:0006119) | 2.92955262 |
| 44 | membrane protein intracellular domain proteolysis (GO:0031293) | 2.92605964 |
| 45 | positive regulation of histone deacetylation (GO:0031065) | 2.91999555 |
| 46 | retinoic acid receptor signaling pathway (GO:0048384) | 2.83943084 |
| 47 | negative regulation of viral release from host cell (GO:1902187) | 2.83905243 |
| 48 | outer ear morphogenesis (GO:0042473) | 2.83602328 |
| 49 | NADH metabolic process (GO:0006734) | 2.83371701 |
| 50 | respiratory system process (GO:0003016) | 2.81216185 |
| 51 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.78316646 |
| 52 | cranial nerve morphogenesis (GO:0021602) | 2.77411912 |
| 53 | cardiac muscle contraction (GO:0060048) | 2.77105754 |
| 54 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 2.75949203 |
| 55 | coronary vasculature morphogenesis (GO:0060977) | 2.75075920 |
| 56 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.69136247 |
| 57 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.68249143 |
| 58 | cardiac myofibril assembly (GO:0055003) | 2.67518099 |
| 59 | lymph vessel development (GO:0001945) | 2.65617369 |
| 60 | response to inactivity (GO:0014854) | 2.64712184 |
| 61 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.63571055 |
| 62 | protein carboxylation (GO:0018214) | 2.63571055 |
| 63 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.61370405 |
| 64 | outflow tract septum morphogenesis (GO:0003148) | 2.60947403 |
| 65 | positive regulation of triglyceride metabolic process (GO:0090208) | 2.60505088 |
| 66 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.60014308 |
| 67 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.60014308 |
| 68 | proline metabolic process (GO:0006560) | 2.59836061 |
| 69 | skeletal muscle adaptation (GO:0043501) | 2.58627847 |
| 70 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.58205738 |
| 71 | NIK/NF-kappaB signaling (GO:0038061) | 2.58189432 |
| 72 | cellular protein complex disassembly (GO:0043624) | 2.58050463 |
| 73 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.57787437 |
| 74 | modulation by symbiont of host cellular process (GO:0044068) | 2.57132105 |
| 75 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.57063443 |
| 76 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 2.55234923 |
| 77 | negative regulation of cell size (GO:0045792) | 2.52491708 |
| 78 | regulation of early endosome to late endosome transport (GO:2000641) | 2.52011878 |
| 79 | glycogen catabolic process (GO:0005980) | 2.50694030 |
| 80 | modulation by virus of host process (GO:0019054) | 2.48834345 |
| 81 | lung morphogenesis (GO:0060425) | 2.48246100 |
| 82 | cellular response to virus (GO:0098586) | 2.48123506 |
| 83 | 2-oxoglutarate metabolic process (GO:0006103) | 2.46140485 |
| 84 | gluconeogenesis (GO:0006094) | 2.45571937 |
| 85 | regulation of fatty acid biosynthetic process (GO:0042304) | 2.45323352 |
| 86 | anatomical structure regression (GO:0060033) | 2.44617237 |
| 87 | positive regulation of T cell apoptotic process (GO:0070234) | 2.44034684 |
| 88 | positive regulation of protein oligomerization (GO:0032461) | 2.43403819 |
| 89 | skeletal muscle cell differentiation (GO:0035914) | 2.42540720 |
| 90 | nucleotide salvage (GO:0043173) | 2.41816906 |
| 91 | negative regulation of cAMP-mediated signaling (GO:0043951) | 2.40734843 |
| 92 | protein insertion into membrane (GO:0051205) | 2.39606309 |
| 93 | pinocytosis (GO:0006907) | 2.38985648 |
| 94 | glucan catabolic process (GO:0009251) | 2.38748611 |
| 95 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.38165682 |
| 96 | muscle fiber development (GO:0048747) | 2.38163821 |
| 97 | focal adhesion assembly (GO:0048041) | 2.37378891 |
| 98 | cell-substrate adherens junction assembly (GO:0007045) | 2.37378891 |
| 99 | positive regulation of protein kinase C signaling (GO:0090037) | 2.36624516 |
| 100 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.36431391 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.63290634 |
| 2 | VDR_21846776_ChIP-Seq_THP-1_Human | 3.57851672 |
| 3 | LXR_22292898_ChIP-Seq_THP-1_Human | 3.16182334 |
| 4 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.87968405 |
| 5 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.59461271 |
| 6 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.45928831 |
| 7 | MYC_22102868_ChIP-Seq_BL_Human | 2.38808481 |
| 8 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.27593835 |
| 9 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.18900908 |
| 10 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.13786241 |
| 11 | KDM2B_26808549_Chip-Seq_DND41_Human | 2.13438602 |
| 12 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.13316354 |
| 13 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 2.06345339 |
| 14 | P68_20966046_ChIP-Seq_HELA_Human | 2.00103172 |
| 15 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.96110895 |
| 16 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.95288040 |
| 17 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.92382261 |
| 18 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.89050495 |
| 19 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.86558794 |
| 20 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.85170163 |
| 21 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.84643077 |
| 22 | KDM2B_26808549_Chip-Seq_K562_Human | 1.78644069 |
| 23 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.77339974 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.72432188 |
| 25 | MAF_26560356_Chip-Seq_TH2_Human | 1.68925868 |
| 26 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.66449000 |
| 27 | * MAF_26560356_Chip-Seq_TH1_Human | 1.65675614 |
| 28 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.64346714 |
| 29 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.63495168 |
| 30 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.61751038 |
| 31 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.59912598 |
| 32 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.58680025 |
| 33 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.57174401 |
| 34 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.56667131 |
| 35 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.55935208 |
| 36 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.54742132 |
| 37 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.53831398 |
| 38 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.53361719 |
| 39 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.53263912 |
| 40 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.50636088 |
| 41 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.46693370 |
| 42 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.46542167 |
| 43 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.46155952 |
| 44 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.45896500 |
| 45 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.44339892 |
| 46 | CTCF_21964334_Chip-Seq_Bcells_Human | 1.44268397 |
| 47 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.43816241 |
| 48 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.43515490 |
| 49 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.43097204 |
| 50 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.41528439 |
| 51 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.41051819 |
| 52 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.39390785 |
| 53 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.35704359 |
| 54 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 1.35222239 |
| 55 | SA1_27219007_Chip-Seq_Bcells_Human | 1.34612801 |
| 56 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.33387107 |
| 57 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.31629828 |
| 58 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.30772970 |
| 59 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.29006302 |
| 60 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.28231812 |
| 61 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.26675506 |
| 62 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.26570006 |
| 63 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.25639385 |
| 64 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.24977318 |
| 65 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.24199801 |
| 66 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.20260017 |
| 67 | RARA_24833708_ChIP-Seq_LIVER_Mouse | 1.19575306 |
| 68 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.18726189 |
| 69 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.18152220 |
| 70 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.17243175 |
| 71 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.15971398 |
| 72 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.15056223 |
| 73 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.14190054 |
| 74 | FOXP1_21924763_ChIP-Seq_HESCs_Human | 1.13075516 |
| 75 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.13014624 |
| 76 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.12986972 |
| 77 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 1.12867796 |
| 78 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.11916829 |
| 79 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.11118722 |
| 80 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.10365963 |
| 81 | ATF3_27146783_Chip-Seq_COLON_Human | 1.10125553 |
| 82 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.09875162 |
| 83 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 1.09610692 |
| 84 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.09464342 |
| 85 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08762582 |
| 86 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.08580853 |
| 87 | RARB_24833708_ChIP-Seq_LIVER_Mouse | 1.08459578 |
| 88 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.07790856 |
| 89 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.07147223 |
| 90 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.05691720 |
| 91 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.04688729 |
| 92 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.02995472 |
| 93 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.02839228 |
| 94 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.02268849 |
| 95 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.01276094 |
| 96 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.01140865 |
| 97 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 1.00191804 |
| 98 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.00176981 |
| 99 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.00091093 |
| 100 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.99918388 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0000751_myopathy | 3.89017628 |
| 2 | MP0010030_abnormal_orbit_morphology | 3.78368646 |
| 3 | MP0005451_abnormal_body_composition | 3.73574846 |
| 4 | MP0009840_abnormal_foam_cell | 3.43252978 |
| 5 | MP0003646_muscle_fatigue | 3.35936230 |
| 6 | MP0004145_abnormal_muscle_electrophysio | 3.07213818 |
| 7 | MP0009278_abnormal_bone_marrow | 2.97737112 |
| 8 | MP0005058_abnormal_lysosome_morphology | 2.91443234 |
| 9 | MP0000750_abnormal_muscle_regeneration | 2.79989934 |
| 10 | MP0003303_peritoneal_inflammation | 2.75090028 |
| 11 | MP0000749_muscle_degeneration | 2.59480342 |
| 12 | MP0000678_abnormal_parathyroid_gland | 2.49179646 |
| 13 | MP0004233_abnormal_muscle_weight | 2.46797576 |
| 14 | MP0000759_abnormal_skeletal_muscle | 2.34823522 |
| 15 | MP0004510_myositis | 2.32319486 |
| 16 | MP0003705_abnormal_hypodermis_morpholog | 2.27944262 |
| 17 | MP0000747_muscle_weakness | 2.23876041 |
| 18 | MP0004130_abnormal_muscle_cell | 2.21747976 |
| 19 | MP0002106_abnormal_muscle_physiology | 2.15900261 |
| 20 | MP0003436_decreased_susceptibility_to | 2.13221323 |
| 21 | MP0004087_abnormal_muscle_fiber | 2.10699791 |
| 22 | MP0005330_cardiomyopathy | 2.06818591 |
| 23 | MP0000733_abnormal_muscle_development | 2.06675667 |
| 24 | MP0002249_abnormal_larynx_morphology | 1.99190323 |
| 25 | MP0002138_abnormal_hepatobiliary_system | 1.80249685 |
| 26 | MP0002332_abnormal_exercise_endurance | 1.79266447 |
| 27 | MP0004036_abnormal_muscle_relaxation | 1.74257906 |
| 28 | MP0003191_abnormal_cellular_cholesterol | 1.73927532 |
| 29 | MP0003123_paternal_imprinting | 1.70320150 |
| 30 | MP0008260_abnormal_autophagy | 1.68600990 |
| 31 | MP0002139_abnormal_hepatobiliary_system | 1.66561977 |
| 32 | MP0005369_muscle_phenotype | 1.65882888 |
| 33 | MP0004185_abnormal_adipocyte_glucose | 1.60710278 |
| 34 | MP0005076_abnormal_cell_differentiation | 1.54432231 |
| 35 | MP0002653_abnormal_ependyma_morphology | 1.46471035 |
| 36 | MP0009333_abnormal_splenocyte_physiolog | 1.42169265 |
| 37 | MP0003453_abnormal_keratinocyte_physiol | 1.39458798 |
| 38 | MP0003172_abnormal_lysosome_physiology | 1.39258445 |
| 39 | MP0001348_abnormal_lacrimal_gland | 1.37574242 |
| 40 | MP0001545_abnormal_hematopoietic_system | 1.30841872 |
| 41 | MP0005397_hematopoietic_system_phenotyp | 1.30841872 |
| 42 | MP0005666_abnormal_adipose_tissue | 1.26780665 |
| 43 | MP0010630_abnormal_cardiac_muscle | 1.25279627 |
| 44 | MP0002269_muscular_atrophy | 1.25130740 |
| 45 | MP0005375_adipose_tissue_phenotype | 1.19030445 |
| 46 | MP0003879_abnormal_hair_cell | 1.18864044 |
| 47 | MP0006036_abnormal_mitochondrial_physio | 1.18820883 |
| 48 | MP0005083_abnormal_biliary_tract | 1.18385679 |
| 49 | MP0004858_abnormal_nervous_system | 1.16965670 |
| 50 | MP0005620_abnormal_muscle_contractility | 1.16529453 |
| 51 | MP0001346_abnormal_lacrimal_gland | 1.16243873 |
| 52 | MP0001849_ear_inflammation | 1.11046153 |
| 53 | MP0001661_extended_life_span | 1.06048068 |
| 54 | MP0005025_abnormal_response_to | 0.97245086 |
| 55 | MP0002132_abnormal_respiratory_system | 0.96259250 |
| 56 | MP0000049_abnormal_middle_ear | 0.95549573 |
| 57 | MP0000003_abnormal_adipose_tissue | 0.94684179 |
| 58 | MP0001873_stomach_inflammation | 0.94663932 |
| 59 | MP0002972_abnormal_cardiac_muscle | 0.92326734 |
| 60 | MP0002127_abnormal_cardiovascular_syste | 0.91283230 |
| 61 | MP0002419_abnormal_innate_immunity | 0.89398658 |
| 62 | MP0008004_abnormal_stomach_pH | 0.88756973 |
| 63 | MP0003806_abnormal_nucleotide_metabolis | 0.85454314 |
| 64 | MP0009379_abnormal_foot_pigmentation | 0.85345473 |
| 65 | MP0003279_aneurysm | 0.85125513 |
| 66 | MP0002234_abnormal_pharynx_morphology | 0.85014704 |
| 67 | MP0002822_catalepsy | 0.84451709 |
| 68 | MP0001663_abnormal_digestive_system | 0.82835412 |
| 69 | MP0003075_altered_response_to | 0.82624479 |
| 70 | MP0005464_abnormal_platelet_physiology | 0.82106196 |
| 71 | MP0002148_abnormal_hypersensitivity_rea | 0.81814678 |
| 72 | MP0005387_immune_system_phenotype | 0.81289324 |
| 73 | MP0001790_abnormal_immune_system | 0.81289324 |
| 74 | MP0002254_reproductive_system_inflammat | 0.79643134 |
| 75 | MP0006138_congestive_heart_failure | 0.78556542 |
| 76 | MP0002163_abnormal_gland_morphology | 0.77287060 |
| 77 | MP0000343_altered_response_to | 0.76554084 |
| 78 | MP0004947_skin_inflammation | 0.75078431 |
| 79 | MP0005670_abnormal_white_adipose | 0.74227517 |
| 80 | MP0005266_abnormal_metabolism | 0.73258258 |
| 81 | MP0003656_abnormal_erythrocyte_physiolo | 0.73235496 |
| 82 | MP0005166_decreased_susceptibility_to | 0.72602517 |
| 83 | MP0005409_darkened_coat_color | 0.72390508 |
| 84 | MP0002837_dystrophic_cardiac_calcinosis | 0.70215105 |
| 85 | MP0002723_abnormal_immune_serum | 0.69823831 |
| 86 | MP0002971_abnormal_brown_adipose | 0.68678044 |
| 87 | MP0008469_abnormal_protein_level | 0.68243367 |
| 88 | MP0005381_digestive/alimentary_phenotyp | 0.68134218 |
| 89 | MP0002089_abnormal_postnatal_growth/wei | 0.67552163 |
| 90 | MP0000685_abnormal_immune_system | 0.64223665 |
| 91 | MP0003878_abnormal_ear_physiology | 0.64190029 |
| 92 | MP0005377_hearing/vestibular/ear_phenot | 0.64190029 |
| 93 | MP0001727_abnormal_embryo_implantation | 0.64160064 |
| 94 | MP0000858_altered_metastatic_potential | 0.63000423 |
| 95 | MP0005000_abnormal_immune_tolerance | 0.60262280 |
| 96 | MP0001533_abnormal_skeleton_physiology | 0.60229625 |
| 97 | MP0002933_joint_inflammation | 0.60157569 |
| 98 | MP0002452_abnormal_antigen_presenting | 0.59987939 |
| 99 | MP0005385_cardiovascular_system_phenoty | 0.58754472 |
| 100 | MP0001544_abnormal_cardiovascular_syste | 0.58754472 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber inclusion bodies (HP:0100299) | 5.96958247 |
| 2 | Exercise-induced myalgia (HP:0003738) | 5.83989605 |
| 3 | Nemaline bodies (HP:0003798) | 5.76295072 |
| 4 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.68172880 |
| 5 | Myopathic facies (HP:0002058) | 5.55310213 |
| 6 | Type 1 muscle fiber predominance (HP:0003803) | 5.11272474 |
| 7 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.91887754 |
| 8 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.72193460 |
| 9 | Bulbar palsy (HP:0001283) | 3.65862136 |
| 10 | Ulnar deviation of the wrist (HP:0003049) | 3.57491760 |
| 11 | Calf muscle hypertrophy (HP:0008981) | 3.50193158 |
| 12 | Asymmetric septal hypertrophy (HP:0001670) | 3.44093787 |
| 13 | Round ear (HP:0100830) | 3.42606067 |
| 14 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.41102930 |
| 15 | Distal arthrogryposis (HP:0005684) | 3.35956838 |
| 16 | Distal lower limb muscle weakness (HP:0009053) | 3.31297996 |
| 17 | Exercise-induced muscle cramps (HP:0003710) | 3.19742320 |
| 18 | Subaortic stenosis (HP:0001682) | 3.15954747 |
| 19 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.15954747 |
| 20 | Increased variability in muscle fiber diameter (HP:0003557) | 3.14586805 |
| 21 | Congenital malformation of the right heart (HP:0011723) | 3.14322815 |
| 22 | Double outlet right ventricle (HP:0001719) | 3.14322815 |
| 23 | Muscle fiber splitting (HP:0003555) | 2.99046992 |
| 24 | Rhabdomyolysis (HP:0003201) | 2.91425471 |
| 25 | Increased connective tissue (HP:0009025) | 2.88706840 |
| 26 | EMG: myopathic abnormalities (HP:0003458) | 2.87418595 |
| 27 | Abnormality of the calf musculature (HP:0001430) | 2.83775319 |
| 28 | Calcaneovalgus deformity (HP:0001848) | 2.81832458 |
| 29 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.79827062 |
| 30 | Recurrent bacterial skin infections (HP:0005406) | 2.77763245 |
| 31 | Progressive muscle weakness (HP:0003323) | 2.70683024 |
| 32 | Hyperthyroidism (HP:0000836) | 2.67840008 |
| 33 | Muscle stiffness (HP:0003552) | 2.62714639 |
| 34 | Difficulty running (HP:0009046) | 2.62522138 |
| 35 | Truncus arteriosus (HP:0001660) | 2.59347630 |
| 36 | Recurrent abscess formation (HP:0002722) | 2.55992304 |
| 37 | Myoglobinuria (HP:0002913) | 2.55808303 |
| 38 | Hyporeflexia of lower limbs (HP:0002600) | 2.52438770 |
| 39 | Increased muscle lipid content (HP:0009058) | 2.49356048 |
| 40 | Ragged-red muscle fibers (HP:0003200) | 2.47495854 |
| 41 | Abnormality of the aortic arch (HP:0012303) | 2.43156549 |
| 42 | Rectal prolapse (HP:0002035) | 2.42986503 |
| 43 | Stridor (HP:0010307) | 2.41608279 |
| 44 | EMG: neuropathic changes (HP:0003445) | 2.37483556 |
| 45 | Increased cerebral lipofuscin (HP:0011813) | 2.35868377 |
| 46 | Deformed tarsal bones (HP:0008119) | 2.35653130 |
| 47 | Thin bony cortex (HP:0002753) | 2.34930741 |
| 48 | Increased intramyocellular lipid droplets (HP:0012240) | 2.32187101 |
| 49 | Cholelithiasis (HP:0001081) | 2.30056008 |
| 50 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.26666807 |
| 51 | Hypertensive crisis (HP:0100735) | 2.17798092 |
| 52 | Malignant hyperthermia (HP:0002047) | 2.16350193 |
| 53 | Obstructive lung disease (HP:0006536) | 2.15513302 |
| 54 | Chronic obstructive pulmonary disease (HP:0006510) | 2.15513302 |
| 55 | Abnormality of the tricuspid valve (HP:0001702) | 2.13500575 |
| 56 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.09829022 |
| 57 | Obstructive sleep apnea (HP:0002870) | 2.08323923 |
| 58 | Easy fatigability (HP:0003388) | 2.07651491 |
| 59 | Spinal rigidity (HP:0003306) | 2.05875095 |
| 60 | Hypoplastic heart (HP:0001961) | 2.04430736 |
| 61 | Neck muscle weakness (HP:0000467) | 2.04360635 |
| 62 | Ventricular tachycardia (HP:0004756) | 2.03710432 |
| 63 | Turricephaly (HP:0000262) | 2.02538769 |
| 64 | Bowel incontinence (HP:0002607) | 2.00841897 |
| 65 | Myotonia (HP:0002486) | 1.99042443 |
| 66 | Abnormal large intestine physiology (HP:0012700) | 1.98793311 |
| 67 | Abnormality of the calcaneus (HP:0008364) | 1.98013986 |
| 68 | Transposition of the great arteries (HP:0001669) | 1.97154342 |
| 69 | Abnormal connection of the cardiac segments (HP:0011545) | 1.97154342 |
| 70 | Abnormal ventriculo-arterial connection (HP:0011563) | 1.97154342 |
| 71 | Difficulty climbing stairs (HP:0003551) | 1.94843617 |
| 72 | Preauricular pit (HP:0004467) | 1.91337213 |
| 73 | Periauricular skin pits (HP:0100277) | 1.91337213 |
| 74 | Waddling gait (HP:0002515) | 1.90710728 |
| 75 | Distal lower limb amyotrophy (HP:0008944) | 1.90601043 |
| 76 | Generalized muscle weakness (HP:0003324) | 1.90063015 |
| 77 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 1.89713022 |
| 78 | Abnormal gallbladder morphology (HP:0012437) | 1.89396893 |
| 79 | Male infertility (HP:0003251) | 1.89027889 |
| 80 | Diaphragmatic weakness (HP:0009113) | 1.86326623 |
| 81 | Achilles tendon contracture (HP:0001771) | 1.85834984 |
| 82 | Mesangial abnormality (HP:0001966) | 1.85679712 |
| 83 | Rimmed vacuoles (HP:0003805) | 1.82865882 |
| 84 | Hemorrhage of the eye (HP:0011885) | 1.82604632 |
| 85 | Decreased activity of cytochrome C oxidase in muscle tissue (HP:0003688) | 1.82349026 |
| 86 | Short palpebral fissure (HP:0012745) | 1.79623412 |
| 87 | Hypoplastic left heart (HP:0004383) | 1.78745160 |
| 88 | Paralysis (HP:0003470) | 1.78318578 |
| 89 | Dilated cardiomyopathy (HP:0001644) | 1.76901065 |
| 90 | Abnormal atrioventricular conduction (HP:0005150) | 1.75783026 |
| 91 | Increased serum ferritin (HP:0003281) | 1.74720533 |
| 92 | Heart block (HP:0012722) | 1.73747953 |
| 93 | Bundle branch block (HP:0011710) | 1.72835717 |
| 94 | Abnormality of the gallbladder (HP:0005264) | 1.72612395 |
| 95 | Fetal akinesia sequence (HP:0001989) | 1.70565801 |
| 96 | Ulnar bowing (HP:0003031) | 1.70025812 |
| 97 | Reticulocytosis (HP:0001923) | 1.69622049 |
| 98 | Neonatal hypoglycemia (HP:0001998) | 1.69412781 |
| 99 | Renal Fanconi syndrome (HP:0001994) | 1.67622477 |
| 100 | Gowers sign (HP:0003391) | 1.67499672 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | SMG1 | 4.16489809 |
| 2 | TRIB3 | 3.93441216 |
| 3 | TTN | 3.36938301 |
| 4 | OBSCN | 3.19887227 |
| 5 | SIK1 | 2.76887889 |
| 6 | NME2 | 2.75920604 |
| 7 | PRPF4B | 2.74810475 |
| 8 | MAP2K3 | 2.53680811 |
| 9 | IRAK3 | 2.50652109 |
| 10 | ERN1 | 2.35798889 |
| 11 | ICK | 2.22528037 |
| 12 | MAP3K11 | 1.97155767 |
| 13 | PHKG1 | 1.90362984 |
| 14 | PHKG2 | 1.90362984 |
| 15 | PRKD3 | 1.86922347 |
| 16 | STK16 | 1.80527437 |
| 17 | RIPK1 | 1.77575123 |
| 18 | VRK2 | 1.58185067 |
| 19 | TAOK2 | 1.53923129 |
| 20 | DYRK1B | 1.53457854 |
| 21 | MAP3K10 | 1.42954727 |
| 22 | IRAK4 | 1.38785054 |
| 23 | TBK1 | 1.37274250 |
| 24 | MAPK12 | 1.32438158 |
| 25 | RPS6KC1 | 1.28781424 |
| 26 | RPS6KL1 | 1.28781424 |
| 27 | TAF1 | 1.27322178 |
| 28 | EEF2K | 1.24783749 |
| 29 | IRAK2 | 1.22819833 |
| 30 | BLK | 1.18875957 |
| 31 | MAPK15 | 1.18399015 |
| 32 | MAP3K3 | 1.15618199 |
| 33 | MAP3K1 | 1.14262663 |
| 34 | MUSK | 1.10604790 |
| 35 | MAP4K1 | 1.10238310 |
| 36 | RPS6KA6 | 1.07188067 |
| 37 | RPS6KA2 | 1.06845336 |
| 38 | TAOK1 | 1.04813712 |
| 39 | TYK2 | 1.01510997 |
| 40 | MARK2 | 0.99325021 |
| 41 | PRKD2 | 0.93117710 |
| 42 | CDC42BPA | 0.90592218 |
| 43 | MAPK11 | 0.88618086 |
| 44 | DYRK3 | 0.87669085 |
| 45 | MAP3K13 | 0.86271207 |
| 46 | EPHB2 | 0.85236364 |
| 47 | HIPK2 | 0.82060119 |
| 48 | BRAF | 0.80675685 |
| 49 | CAMK1D | 0.80087190 |
| 50 | MOS | 0.79164297 |
| 51 | ABL2 | 0.78050447 |
| 52 | ARAF | 0.72798023 |
| 53 | PDPK1 | 0.72348247 |
| 54 | MAPK4 | 0.71822425 |
| 55 | TNK2 | 0.71273566 |
| 56 | GRK6 | 0.70957943 |
| 57 | MAP3K7 | 0.69702252 |
| 58 | IKBKB | 0.69479951 |
| 59 | PKN2 | 0.69292624 |
| 60 | DMPK | 0.67229672 |
| 61 | DAPK3 | 0.65337362 |
| 62 | CSK | 0.64824727 |
| 63 | MTOR | 0.61524788 |
| 64 | RIPK4 | 0.61415503 |
| 65 | CDK19 | 0.60599944 |
| 66 | MAP2K2 | 0.60479959 |
| 67 | STK11 | 0.59770658 |
| 68 | BMX | 0.58389863 |
| 69 | ZAP70 | 0.58368665 |
| 70 | EPHB1 | 0.57890203 |
| 71 | BCKDK | 0.55810231 |
| 72 | CDK4 | 0.53691709 |
| 73 | MELK | 0.53650164 |
| 74 | MAPK7 | 0.53460678 |
| 75 | NME1 | 0.53428572 |
| 76 | RPS6KA1 | 0.52367257 |
| 77 | KSR2 | 0.52141472 |
| 78 | LRRK2 | 0.51377261 |
| 79 | PTK6 | 0.50187646 |
| 80 | MAP2K6 | 0.50103214 |
| 81 | PIK3CG | 0.50043848 |
| 82 | MAP2K4 | 0.43516732 |
| 83 | CHUK | 0.42392047 |
| 84 | MATK | 0.42117112 |
| 85 | TYRO3 | 0.41130127 |
| 86 | PRKAA2 | 0.40742169 |
| 87 | MAP3K6 | 0.39715648 |
| 88 | PRKAA1 | 0.39494160 |
| 89 | PIM2 | 0.39020332 |
| 90 | FGFR4 | 0.38569160 |
| 91 | MAP3K8 | 0.36982012 |
| 92 | BTK | 0.35999509 |
| 93 | CAMK4 | 0.33402189 |
| 94 | IKBKE | 0.33198223 |
| 95 | JAK3 | 0.32681664 |
| 96 | TGFBR2 | 0.31952870 |
| 97 | EPHA2 | 0.31661611 |
| 98 | PDK1 | 0.31235943 |
| 99 | DDR2 | 0.30331057 |
| 100 | PRKG2 | 0.29852620 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sulfur relay system_Homo sapiens_hsa04122 | 4.72791651 |
| 2 | Other glycan degradation_Homo sapiens_hsa00511 | 3.34680242 |
| 3 | Notch signaling pathway_Homo sapiens_hsa04330 | 2.75339702 |
| 4 | Ribosome_Homo sapiens_hsa03010 | 2.67389576 |
| 5 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.40095873 |
| 6 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.19197205 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.09742361 |
| 8 | Galactose metabolism_Homo sapiens_hsa00052 | 1.87923303 |
| 9 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.85800282 |
| 10 | Bladder cancer_Homo sapiens_hsa05219 | 1.77835241 |
| 11 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.67200770 |
| 12 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.65116539 |
| 13 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.64096196 |
| 14 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.58727746 |
| 15 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.56829771 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.53765912 |
| 17 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.53484306 |
| 18 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.53475155 |
| 19 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.51987064 |
| 20 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.50438929 |
| 21 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.49210260 |
| 22 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.44316704 |
| 23 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.42377331 |
| 24 | Insulin resistance_Homo sapiens_hsa04931 | 1.40546051 |
| 25 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.34824176 |
| 26 | Carbon metabolism_Homo sapiens_hsa01200 | 1.31773050 |
| 27 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.22896041 |
| 28 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.22546523 |
| 29 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.16677956 |
| 30 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.16193951 |
| 31 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.16179753 |
| 32 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.15576014 |
| 33 | Lysosome_Homo sapiens_hsa04142 | 1.15313671 |
| 34 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.12378981 |
| 35 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.11501356 |
| 36 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.10574383 |
| 37 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.08574058 |
| 38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.08099035 |
| 39 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.07624779 |
| 40 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.06588935 |
| 41 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.05796296 |
| 42 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.05733855 |
| 43 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.01082350 |
| 44 | Leishmaniasis_Homo sapiens_hsa05140 | 0.94655436 |
| 45 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.93020195 |
| 46 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.92678146 |
| 47 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.92409172 |
| 48 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.91521574 |
| 49 | Prion diseases_Homo sapiens_hsa05020 | 0.90056243 |
| 50 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.86298324 |
| 51 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.86229864 |
| 52 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.85050019 |
| 53 | Hepatitis C_Homo sapiens_hsa05160 | 0.80001899 |
| 54 | Tuberculosis_Homo sapiens_hsa05152 | 0.77761167 |
| 55 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.75774317 |
| 56 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75331106 |
| 57 | Malaria_Homo sapiens_hsa05144 | 0.74211686 |
| 58 | Endometrial cancer_Homo sapiens_hsa05213 | 0.72510589 |
| 59 | Hepatitis B_Homo sapiens_hsa05161 | 0.71137260 |
| 60 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.71101913 |
| 61 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.70841321 |
| 62 | Base excision repair_Homo sapiens_hsa03410 | 0.70607467 |
| 63 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.70129990 |
| 64 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.67893303 |
| 65 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.66478118 |
| 66 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.65897099 |
| 67 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.65608151 |
| 68 | Apoptosis_Homo sapiens_hsa04210 | 0.63582952 |
| 69 | HTLV-I infection_Homo sapiens_hsa05166 | 0.63333201 |
| 70 | Alzheimers disease_Homo sapiens_hsa05010 | 0.60664958 |
| 71 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.59852571 |
| 72 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.59416562 |
| 73 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.57747242 |
| 74 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.56117651 |
| 75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55696419 |
| 76 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.55136137 |
| 77 | Pertussis_Homo sapiens_hsa05133 | 0.54587699 |
| 78 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.54156757 |
| 79 | Influenza A_Homo sapiens_hsa05164 | 0.50724632 |
| 80 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.50641296 |
| 81 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.48427777 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.48407919 |
| 83 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.48388695 |
| 84 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.47822349 |
| 85 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.47790752 |
| 86 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.47102231 |
| 87 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.46755835 |
| 88 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.46707966 |
| 89 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.42265782 |
| 90 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.41673466 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41191482 |
| 92 | Parkinsons disease_Homo sapiens_hsa05012 | 0.41038175 |
| 93 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.40214035 |
| 94 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.39888764 |
| 95 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.38360215 |
| 96 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.38352549 |
| 97 | Melanogenesis_Homo sapiens_hsa04916 | 0.37150649 |
| 98 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.36714355 |
| 99 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.36397374 |
| 100 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.35912033 |

